October is Women’s History Month: Read how Federated Health Charities support female-led research in diagnosing cancer using Artificial Intelligence.
The Canadian Cancer Society (CCS) is funding groundbreaking research that will standardize cancer diagnosis globally. Dr. April Khademi, a biomedical engineer at Toronto’s Metropolitan University, has created an AI (Artificial Intelligence) tool that will help pathologists make more consistent and reliable breast cancer diagnoses and treatment decisions.
The 2024 report profiling Dr. Khademi’s research published in Scientific Reports, reveals that AI demonstrated statistical superiority and improved accuracy in diagnosing breast cancer over traditional non-AI methods. This advancement suggests that AI tools can enhance diagnostic precision, potentially leading to earlier detection and more personalized treatment plans, aiding doctors in making informed decisions. “The potential is significant,” Khademi says. “The goal of AI is to make the assessment more standardized and more reproducible. If I assessed a slide using AI and my colleague across the street assessed the same slide next week, we’ll get the same score. That’s standardization.”
AI technology in accurate breast cancer diagnosis Dr April Khademi research
Dr. Khademi’s research continues into 2025 as the team focuses on expanding application of the AI tool on larger populations and data sets before it becomes standard practice in the future.
The Canadian Cancer Society is a trusted partner and one of the 21 charities your Federated Health donations support. When you donate to the Canadian Cancer Society, one of the areas your dollars support is important research, like that of Dr. Khademi. To support this and other types of important work, donate to the Canadian Cancer Society today.
